Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy

Por Karakousis, Giorgos C., Alexander, H. Richard
Publicado no J Gastrointest Oncol (2016)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality

Por Newton, Andrew D., Bartlett, Edmund K., Karakousis, Giorgos C.
Publicado no J Gastrointest Oncol (2016)

Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective

Por Neuwirth, Madalyn G., Alexander, H. Richard, Karakousis, Giorgos C.
Publicado no J Gastrointest Oncol (2016)

Development and implementation of a clinical pathway approach to simulation-based training for foregut surgery

Por Miyasaka, Kiyoyuki W, Buchholz, Joseph, LaMarra, Denise, Karakousis, Giorgos C, Aggarwal, Rajesh
Publicado no J Surg Educ (2015)

Neoadjuvant therapy for gastric cancer: current evidence and future directions

Por Newton, Andrew D., Datta, Jashodeep, Loaiza-Bonilla, Arturo, Karakousis, Giorgos C., Roses, Robert E.
Publicado no J Gastrointest Oncol (2015)

Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma

Por Marek, Andrew J., Ming, Michael E., Bartlett, Edmund K., Karakousis, Giorgos C., Chu, Emily Y.
Publicado no JAMA Dermatol (2016)

Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison

Por Karakousis, Giorgos C., Singer, Samuel, Zheng, Junting, Gonen, Mithat, Coit, Daniel, DeMatteo, Ronald P., Strong, Vivian E.
Publicado no Ann Surg Oncol (2011)

Prognosis of Patients with Melanoma and Microsatellitosis Undergoing Sentinel Lymph Node Biopsy

Por Bartlett, Edmund K., Gupta, Meera, Datta, Jashodeep, Gimotty, Phyllis A., Guerry, DuPont, Xu, Xiaowei, Elder, David E., Czerniecki, Brian J., Fraker, Douglas L., Karakousis, Giorgos C.
Publicado em 2013

Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity

Por Bartlett, Edmund K., Peters, Madalyn G., Blair, Anne, Etherington, Mark S., Elder, David E., Xu, Xiaowei G., Guerry, DuPont, Ming, Michael E., Fraker, Douglas L., Czerniecki, Brian J., Gimotty, Phyllis A., Karakousis, Giorgos C.
Publicado no Ann Surg Oncol (2015)

Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3

Por Abel, Ethan V., Basile, Kevin J., Kugel, Curtis H., Witkiewicz, Agnieszka K., Le, Kaitlyn, Amaravadi, Ravi K., Karakousis, Giorgos C., Xu, Xiaowei, Xu, Wei, Schuchter, Lynn M., Lee, Jason B., Ertel, Adam, Fortina, Paolo, Aplin, Andrew E.
Publicado em 2013

Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy

Por Bartlett, Edmund K., Gimotty, Phyllis A., Sinnamon, Andrew J., Wachtel, Heather, Roses, Robert E., Schuchter, Lynn, Xu, Xiaowei, Elder, David E., Ming, Michael, Elenitsas, Rosalie, Guerry, DuPont, Kelz, Rachel R., Czerniecki, Brian J., Fraker, Douglas L., Karakousis, Giorgos C.
Publicado em 2013

Oncogenic BRAF-mediated Melanoma Cell Invasion

Por Lu, Hezhe, Liu, Shujing, Zhang, Gao, Kwong, Lawrence N., Zhu, Yueyao, Miller, John P., Hu, Yi, Zhong, Wenqun, Zeng, Jingwen, Wu, Lawrence, Krepler, Clemens, Sproesser, Katrin, Xiao, Min, Xu, Wei, Karakousis, Giorgos C., Schuchter, Lynn M., Field, Jeffery, Zhang, Paul J., Herlyn, Meenhard, Xu, Xiaowei, Guo, Wei
Publicado no Cell Rep (2016)

Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2

Por O’Connell, Michael P., Marchbank, Katie, Webster, Marie R., Valiga, Alexander A., Kaur, Amanpreet, Vultur, Adina, Li, Ling, Herlyn, Meenhard, Villanueva, Jessie, Liu, Qin, Yin, Xiangfan, Widura, Sandy, Nelson, Janelle, Ruiz, Nivia, Camilli, Tura C., Indig, Fred E., Flaherty, Keith T., Wargo, Jennifer A., Frederick, Dennie T., Cooper, Zachary A., Nair, Suresh, Amaravadi, Ravi K., Schuchter, Lynn M., Karakousis, Giorgos C., Xu, Wei, Xu, Xiaowei, Weeraratna, Ashani T.
Publicado em 2013

Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma

Por Villanueva, Jessie, Infante, Jeffrey R., Krepler, Clemens, Reyes-Uribe, Patricia, Samanta, Minu, Chen, Hsin-Yi, Li, Bin, Swoboda, Rolf K., Wilson, Melissa, Vultur, Adina, Fukunaba-Kalabis, Mizuho, Wubbenhorst, Bradley, Chen, Thomas Y., Liu, Qin, Sproesser, Katrin, DeMarini, Douglas J., Gilmer, Tona M., Martin, Anne-Marie, Marmorstein, Ronen, Schultz, David C., Speicher, David W., Karakousis, Giorgos C., Xu, Wei, Amaravadi, Ravi K., Xu, Xiaowe, Schuchter, Lynn M., Herlyn, Meenhard, Nathanson, Katherine L.
Publicado em 2013

Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors

Por Zhang, Gao, Frederick, Dennie T., Wu, Lawrence, Wei, Zhi, Krepler, Clemens, Srinivasan, Satish, Chae, Young Chan, Xu, Xiaowei, Choi, Harry, Dimwamwa, Elaida, Ope, Omotayo, Shannan, Batool, Basu, Devraj, Zhang, Dongmei, Guha, Manti, Xiao, Min, Randell, Sergio, Sproesser, Katrin, Xu, Wei, Liu, Jephrey, Karakousis, Giorgos C., Schuchter, Lynn M., Gangadhar, Tara C., Amaravadi, Ravi K., Gu, Mengnan, Xu, Caiyue, Ghosh, Abheek, Xu, Weiting, Tian, Tian, Zhang, Jie, Zha, Shijie, Liu, Qin, Brafford, Patricia, Weeraratna, Ashani, Davies, Michael A., Wargo, Jennifer A., Avadhani, Narayan G., Lu, Yiling, Mills, Gordon B., Altieri, Dario C., Flaherty, Keith T., Herlyn, Meenhard
Publicado no J Clin Invest (2016)

The State of Melanoma: Challenges and Opportunities

Por Merlino, Glenn, Herlyn, Meenhard, Fisher, David E., Bastian, Boris C., Flaherty, Keith T., Davies, Michael A., Wargo, Jennifer A., Curiel-Lewandrowski, Clara, Weber, Michael J., Leachman, Sancy A., Soengas, Maria S., McMahon, Martin, Harbour, J. William, Swetter, Susan M., Aplin, Andrew E., Atkins, Michael B., Bosenberg, Marcus W., Dummer, Reinhard, Gershenwald, Jeff, Halpern, Allan C., Herlyn, Dorothee, Karakousis, Giorgos C., Kirkwood, John M., Krauthammer, Michael, Lo, Roger S., Long, Georgina V., McArthur, Grant, Ribas, Antoni, Schuchter, Lynn, Sosman, Jeffrey A., Smalley, Keiran S., Steeg, Patricia, Thomas, Nancy E., Tsao, Hensin, Tueting, Thomas, Weeraratna, Ashani, Xu, George, Lomax, Randy, Martin, Alison, Silverstein, Steve, Turnham, Tim, Ronai, Ze’ev A.
Publicado no Pigment Cell Melanoma Res (2016)